Hvsen Biotechnology Co., Ltd.
SZSE:300871.SZ
Overview | Financials
Company Name | Hvsen Biotechnology Co., Ltd. |
Symbol | 300871.SZ |
Currency | CNY |
Price | 14.16 |
Market Cap | 2,348,960,033 |
Dividend Yield | 2.03% |
52-week-range | 13.61 - 26.03 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Kaijie Yang |
Website | https://www.whhsyy.com |
An error occurred while fetching data.
About Hvsen Biotechnology Co., Ltd.
Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin raw materials, various tylvalosin preparations, florfenicol preparations, and other macrolides products. The company produces various veterinary drug products of raw materials and preparations, as well
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD